Catheter Precision
VTAK
10 hedge funds and large institutions have $389K invested in Catheter Precision in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
121% more capital invested
Capital invested by funds: $177K → $389K (+$213K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.02% more ownership
Funds ownership: 0.03% → 0.06% (+0.02%)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$177K |
| 2 |
Millennium Management
New York
|
+$5.25K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$89 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$10K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$89 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $302K | +$177K | +1,991 | +156% |
|
2
Baird Financial Group
Milwaukee,
Wisconsin
| $48.9K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $14.3K | – | – | – |
|
4
BlackRock
New York
| $8.96K | – | – | – |
|
|
5
Millennium Management
New York
| $5.45K | +$5.25K | +59 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $5.04K | -$89 | -1 | -2% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3.78K | +$89 | +1 | +3% |
|
|
HI
8
Harbour Investments
Madison,
Wisconsin
| $739 | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $97 | – | – | – |
|
|
APC
10
Aspire Private Capital
Cornelius,
North Carolina
| $58 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $29 | – | – | – |
|
12
Qube Research & Technologies (QRT)
London,
United Kingdom
| $3 | – | – | – |
|
|
KFI
13
Key Financial Inc
West Chester,
Pennsylvania
| $1 | – | – | – |
|
|
14
Renaissance Technologies
New York
| – | -$10K | -129 | Closed |
|
VTAK Hedge Fund Activity: Q1 2024 in Review
10 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2024, worth a combined $389K — up 121% from $177K a quarter earlier.
Fund positioning in VTAK was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, adding an estimated $177K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $10K sold.
- 10 institutional investors held Catheter Precision (VTAK) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $389K of Catheter Precision stock for Q1 2024, up 121% quarter-over-quarter.
- 1 fund opened new Catheter Precision positions in Q1 2024 and 1 closed out, a net change of 0 holders.
- The largest Catheter Precision buyer in Q1 2024 was Armistice Capital, an estimated $177K added.
- The largest Catheter Precision seller in Q1 2024 was Renaissance Technologies, an estimated $10K sold.
Based on aggregated 13F filings for Q1 2024.